BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16649999)

  • 21. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain.
    Narayan S; Kass KE; Thomas EA
    J Neurosci Res; 2007 Mar; 85(4):757-65. PubMed ID: 17177202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
    Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
    Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of phosphatidylcholine and sphingomyelin molecular species from brain extracts using capillary liquid chromatography electrospray ionization mass spectrometry.
    Isaac G; Bylund D; Månsson JE; Markides KE; Bergquist J
    J Neurosci Methods; 2003 Sep; 128(1-2):111-9. PubMed ID: 12948554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
    Fredriksson A; Archer T
    Neurotox Res; 2006 Jun; 9(4):305-12. PubMed ID: 16782590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats.
    Terry AV; Parikh V; Gearhart DA; Pillai A; Hohnadel E; Warner S; Nasrallah HA; Mahadik SP
    J Pharmacol Exp Ther; 2006 Aug; 318(2):709-24. PubMed ID: 16702442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms.
    Lu Y; Hong S; Yang R; Uddin J; Gotlinger KH; Petasis NA; Serhan CN
    Rapid Commun Mass Spectrom; 2007; 21(1):7-22. PubMed ID: 17131464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spontaneous motor activity and brain catecholamines in C57BL/6 and albino mice treated with manganese].
    Martínez HJ; Castro-Caraballo F; Arrieta A; Bonilla E
    Invest Clin; 2004 Mar; 45(1):3-15. PubMed ID: 15058754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations.
    Soiza-Reilly M; Azcurra JM
    Neurotoxicol Teratol; 2009; 31(4):191-7. PubMed ID: 19336253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study.
    Robbins MJ; Critchlow HM; Lloyd A; Cilia J; Clarke JD; Bond B; Jones DN; Maycox PR
    J Psychopharmacol; 2008 Jul; 22(5):536-42. PubMed ID: 18208916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
    Casademont J; Garrabou G; Miró O; López S; Pons A; Bernardo M; Cardellach F
    J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment.
    McNamara RK; Sullivan J; Richtand NM
    J Psychiatr Res; 2008 May; 42(6):458-68. PubMed ID: 17628596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine.
    Ko F; Tallerico T; Seeman P
    Synapse; 2006 Aug; 60(2):141-51. PubMed ID: 16715494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex.
    Verma V; Lim EP; Han SP; Nagarajah R; Dawe GS
    Neurosci Res; 2007 Jan; 57(1):17-28. PubMed ID: 17028028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective increases in regional brain glucocorticoid: a novel effect of chronic alcohol.
    Little HJ; Croft AP; O'Callaghan MJ; Brooks SP; Wang G; Shaw SG
    Neuroscience; 2008 Oct; 156(4):1017-27. PubMed ID: 18801418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia.
    Maehara S; Hikichi H; Satow A; Okuda S; Ohta H
    Pharmacol Biochem Behav; 2008 Nov; 91(1):140-9. PubMed ID: 18651995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.